{"id":31295,"date":"2026-02-08T17:46:44","date_gmt":"2026-02-08T17:46:44","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/electronic-clinical-outcome-assessment-solutions-ecoa-market-mordor\/"},"modified":"2026-10-09T12:16:50","modified_gmt":"2026-10-09T03:16:50","slug":"electronic-clinical-outcome-assessment-solutions-ecoa-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/electronic-clinical-outcome-assessment-solutions-ecoa-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc804\uc790 \uc784\uc0c1 \uacb0\uacfc \ud3c9\uac00 \uc194\ub8e8\uc158 (ECOA) \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026 &#8211; 2031)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/electronic-clinical-outcome-assessment-solutions-ecoa-market-1729157760651-234567.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/electronic-clinical-outcome-assessment-solutions-ecoa-market-size-image-1767808077985.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">\n    1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          1.2 \uc5f0\uad6c \ubc94\uc704<\/p>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">\n    2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">\n    3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">\n    4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          4.1 \uc2dc\uc7a5 \uac1c\uc694<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.2 \uc2dc\uc7a5 \ub3d9\uc778<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.2.1 \uc81c\uc57d \ubc0f \ubc14\uc774\uc624\ud14d \uc2a4\ud3f0\uc11c\uc758 \uc784\uc0c1 \uc2dc\ud5d8 \uc544\uc6c3\uc18c\uc2f1 \uc99d\uac00<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.2 \ud074\ub77c\uc6b0\ub4dc\/SaaS \uae30\ubc18 eClinical \uc2a4\ud0dd \ud655\uc7a5<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.3 \ud658\uc790 \uc911\uc2ec \uc57d\ubb3c \uac1c\ubc1c\uc744 \uc704\ud55c \uaddc\uc81c \uac15\ud654<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.4 \ubd84\uc0b0\ud615 \ubc0f BYOD \uc784\uc0c1 \uc2dc\ud5d8 \ubaa8\ub378\ub85c\uc758 \uc804\ud658 \uac00\uc18d\ud654<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.5 BYOD \uc9c0\uc6d0 \uc6e8\uc5b4\ub7ec\ube14 \uae30\uae30\uac00 \uae30\uae30 \ube44\uc6a9\uc744 \uc808\uac10\ud558\uace0 \uaddc\uc815 \uc900\uc218\uc728\uc744 \ub192\uc784<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.6 AI \uae30\ubc18 \uc21c\uc751\ub3c4 \ucf54\uce6d\uc774 PRO \ub370\uc774\ud130 \ud488\uc9c8 \ud5a5\uc0c1<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.3 \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.3.1 \ub370\uc774\ud130 \ubcf4\uc548 \ubc0f \uac1c\uc778 \uc815\ubcf4 \uce68\ud574 \uc6b0\ub824<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.2 \ub192\uc740 \ucd08\uae30 \uad6c\ud604 \ubc0f \uac80\uc99d \ube44\uc6a9<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.3 eCOA \uc219\ub828 \uc784\uc0c1 \uc6b4\uc601 \uc778\ub825 \ubd80\uc871<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.4 \uae30\uae30 \uc774\uc9c8\uc131\uc73c\ub85c \uc778\ud55c \uce21\uc815 \ub3d9\ub4f1\uc131 \uc704\ud5d8<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.4 \uaddc\uc81c \ud658\uacbd<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.5 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.5.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.5 \uacbd\uc7c1 \uac15\ub3c4<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">\n    5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          5.1 \uc81c\uacf5 \ubc29\uc2dd\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.1.1 \uc6f9 \ud638\uc2a4\ud305<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.2 \ud074\ub77c\uc6b0\ub4dc \uae30\ubc18<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.3 \uc628\ud504\ub808\ubbf8\uc2a4<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.2 \uc811\uadfc \ubc29\uc2dd\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.2.1 \ud658\uc790 \ubcf4\uace0 \uacb0\uacfc (PRO)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.2 \uc784\uc0c1\uc758 \ubcf4\uace0 \uacb0\uacfc (ClinRO)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.3 \uad00\ucc30\uc790 \ubcf4\uace0 \uacb0\uacfc (ObsRO)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.4 \uc131\uacfc \uacb0\uacfc (PerfO)<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.3 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.3.1 \uc81c\uc57d \ubc0f \ubc14\uc774\uc624\uc81c\uc57d \ud68c\uc0ac<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.2 \uc784\uc0c1\uc2dc\ud5d8\uc218\ud0c1\uae30\uad00 (CRO)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.3 \uae30\ud0c0<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.4 \uc9c0\uc5ed\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.4.1 \ubd81\ubbf8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.1 \ubbf8\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.2 \uce90\ub098\ub2e4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.3 \uba55\uc2dc\ucf54<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.2 \uc720\ub7fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.1 \ub3c5\uc77c<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.2 \uc601\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.3 \ud504\ub791\uc2a4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.4 \uc774\ud0c8\ub9ac\uc544<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.5 \uc2a4\ud398\uc778<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.6 \uae30\ud0c0 \uc720\ub7fd<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.1 \uc911\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.2 \uc77c\ubcf8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.3 \uc778\ub3c4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.4 \ud638\uc8fc<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.5 \ub300\ud55c\ubbfc\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.1 GCC<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.2 \ub0a8\uc544\ud504\ub9ac\uce74 \uacf5\ud654\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.5 \ub0a8\ubbf8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.1 \ube0c\ub77c\uc9c8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">\n    6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.3 \ud68c\uc0ac \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uc218\uc900 \uac1c\uc694, \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          6.3.1 \ub2e4\uc3d8 \uc2dc\uc2a4\ud15c\uc988 (\uba54\ub514\ub370\uc774\ud130)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.2 \uc2dc\uadf8\ub10c\ud2b8 \ud5ec\uc2a4<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.3 \ud074\ub77c\ub9ac\uc624 (ERT \ud074\ub9ac\ub2c8\uceec)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.4 \uc624\ub77c\ud074 \ucf54\ud37c\ub808\uc774\uc158<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.5 \uc544\uc774\ud050\ube44\uc544 Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.6 \ube44\ubc14 \uc2dc\uc2a4\ud15c\uc988<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.7 \ud30c\ub809\uc140 \uc778\ud130\ub0b4\uc154\ub110 \ucf54\ud37c\ub808\uc774\uc158<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.8 \uce74\uc60c\ud2f0\uc2a4<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.9 \uce90\uc2a4\ud130 EDC<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.10 WCG \ud074\ub9ac\ub2c8\uceec<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.11 \uba54\ub4dc\ub137 \uc194\ub8e8\uc158\uc988<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.12 \uc544\ub9ac\uc2a4\uae00\ub85c\ubc8c<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.13 \uba54\ub354\ube14 Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.14 \uc218\ubcf4\ub2e4<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.15 \ud2b8\ub77c\uc774\uc5bc\uc2a4\ud30c\ud06c<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.16 \uc774\ud074\ub9ac\ub2c8\uceec \uc194\ub8e8\uc158\uc988 LLC<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.17 \uc624\ud508\ud074\ub9ac\ub2c8\uce74<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.18 \uc548\uc8fc \uc18c\ud504\ud2b8\uc6e8\uc5b4<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.19 CRF \ud5ec\uc2a4 (\ud30c\ub809\uc140)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.20 \uc634\ub2c8\ucf64 \uc2dc\uc2a4\ud15c\uc988<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.21 \uce90\uc2a4\ud130 (\ud074\ub77c\uc6b0\ub4dc \uc194\ub8e8\uc158\uc988)<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">\n    7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc804\uc790 \uc784\uc0c1 \uacb0\uacfc \ud3c9\uac00 \uc194\ub8e8\uc158(eCOA) \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc804\ub9dd (2026-2031)<\/p>\n<p># 1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc131\uc7a5 \uc804\ub9dd<\/p>\n<p>\uc804\uc790 \uc784\uc0c1 \uacb0\uacfc \ud3c9\uac00 \uc194\ub8e8\uc158(eCOA) \uc2dc\uc7a5\uc740 2025\ub144 21\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 25\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud588\uc73c\uba70, 2031\ub144\uc5d0\ub294 51\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4. \uc774\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 15.42%\uc758 \uacac\uace0\ud55c \uc131\uc7a5\ub960\uc744 \uc758\ubbf8\ud569\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \ud658\uc790 \uc911\uc2ec \uc99d\uac70\uc5d0 \ub300\ud55c \uaddc\uc81c \ub2f9\uad6d\uc758 \uc9d1\uc911 \uac15\ud654, \ud074\ub77c\uc6b0\ub4dc \uae30\ubc18 eClinical \uc2a4\ud0dd\uc73c\ub85c\uc758 \ube60\ub978 \uc804\ud658, \uadf8\ub9ac\uace0 \ubd84\uc0b0\ud615 \uc784\uc0c1 \uc2dc\ud5d8 \ubaa8\ub378\uc758 \uad11\ubc94\uc704\ud55c \ucc44\ud0dd\uc5d0 \uc758\ud574 \uac00\uc18d\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc81c\uc57d \uc2a4\ud3f0\uc11c\ub4e4\uc740 eCOA \uc2dc\uc2a4\ud15c\uc744 \ud658\uc790 \ubcf4\uace0 \uacb0\uacfc(PRO), \uc784\uc0c1\uc758 \ubcf4\uace0 \uacb0\uacfc(ClinRO), \uad00\ucc30\uc790 \ubcf4\uace0 \uacb0\uacfc(ObsRO), \uc218\ud589 \uacb0\uacfc(PerfO) \ub4f1 \uace0\ud488\uc9c8\uc758 \ub370\uc774\ud130\ub97c \uc218\uc9d1\ud558\ub294 \ud575\uc2ec \uba54\ucee4\ub2c8\uc998\uc73c\ub85c \uc778\uc2dd\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc774\uba70, \ubd81\ubbf8\uac00 \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc744 \ud615\uc131\ud558\uace0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc138\ub97c \ubcf4\uc77c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p># 2. \uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\uc778 (Drivers)<\/p>\n<p>eCOA \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \ub3d9\uc778\ub4e4\uc740 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc81c\uc57d \ubc0f \ubc14\uc774\uc624 \uc2a4\ud3f0\uc11c\uc758 \uc784\uc0c1 \uc2dc\ud5d8 \uc544\uc6c3\uc18c\uc2f1 \uc99d\uac00 (+2.8% CAGR \uc601\ud5a5): \uc2a4\ud3f0\uc11c\ub4e4\uc774 \ud575\uc2ec \uc5f0\uad6c \uac1c\ubc1c \ud65c\ub3d9\uc5d0 \uc9d1\uc911\ud568\uc5d0 \ub530\ub77c \uc784\uc0c1 \uc2dc\ud5d8 \uc2e4\ud589\uc758 \uc0c1\ub2f9 \ubd80\ubd84\uc744 \uacc4\uc57d \uc5f0\uad6c \uae30\uad00(CRO)\uc5d0 \uc704\ud0c1\ud558\ub294 \uacbd\ud5a5\uc774 \uc2ec\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. CRO\ub4e4\uc740 \ud1b5\ud569\ub41c eCOA \ud50c\ub7ab\ud3fc\uc744 \ucc44\ud0dd\ud558\uc5ec \ub370\uc774\ud130 \uc218\uc9d1, \ubb34\uc791\uc704 \ubc30\uc815, \ud658\uc790 \ucc38\uc5ec \uc11c\ube44\uc2a4\ub97c \ub300\uaddc\ubaa8\ub85c \uc81c\uacf5\ud558\uba70, Suvoda-Greenphire \ud569\ubcd1\uacfc \uac19\uc740 \ud1b5\ud569 \uc0ac\ub840\ub294 eCOA, \uacb0\uc81c, \uacf5\uae09\ub9dd \uae30\ub2a5\uc744 \uc544\uc6b0\ub974\ub294 \ud1b5\ud569 \uc0dd\ud0dc\uacc4\ub97c \uad6c\ucd95\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ubd81\ubbf8\uc640 \uc720\ub7fd\uc744 \uc911\uc2ec\uc73c\ub85c \uc804 \uc138\uacc4\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\uce58\uba70 \uc911\uae30\uc801\uc778(2-4\ub144) \uc131\uc7a5\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4.<br \/>\n*   \ud074\ub77c\uc6b0\ub4dc\/SaaS \uae30\ubc18 eClinical \uc2a4\ud0dd\uc758 \ud655\uc7a5 (+3.1% CAGR \uc601\ud5a5): \uc2a4\ud3f0\uc11c\ub4e4\uc774 \ud0c4\ub825\uc801\uc778 \uc6a9\ub7c9, \uc2e4\uc2dc\uac04 \ubd84\uc11d, \uc790\ub3d9\ud654\ub41c \uaddc\uc81c \uc5c5\ub370\uc774\ud2b8\ub97c \ucd94\uad6c\ud558\uba74\uc11c \ud074\ub77c\uc6b0\ub4dc \ubc30\ud3ec\uac00 \uae30\uc874 \uc6f9 \ud638\uc2a4\ud305 \ubaa8\ub378\uc744 \ub2a5\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. FDA\uc758 \ucef4\ud4e8\ud130 \uc18c\ud504\ud2b8\uc6e8\uc5b4 \ubcf4\uc99d(CSA) \uc9c0\uce68\uc740 \uc704\ud5d8 \uae30\ubc18 \uac80\uc99d\uc744 \uc9c0\uc6d0\ud558\uc5ec \ud074\ub77c\uc6b0\ub4dc \ucc44\ud0dd\uc758 \uc7a5\ubcbd\uc744 \ub0ae\ucd94\uace0 21 CFR Part 11 \uc694\uad6c \uc0ac\ud56d\uc744 \ucda9\uc871\uc2dc\ud0b5\ub2c8\ub2e4. Microsoft Azure\uc640 \uac19\uc740 \uc8fc\uc694 \ud074\ub77c\uc6b0\ub4dc \uc81c\uacf5\uc5c5\uccb4\ub294 SOC 1, SOC 2, ISO\/IEC 27001 \ud45c\uc900\uc744 \ucda9\uc871\ud558\uc5ec \uc0dd\uba85 \uacfc\ud559 \ud300\uc5d0 \uc989\uc2dc \uc0ac\uc6a9 \uac00\ub2a5\ud55c \ubcf4\uc548 \ud504\ub808\uc784\uc6cc\ud06c\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc774\ub294 \ubd81\ubbf8 \uc8fc\ub3c4\ub85c \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\uc73c\ub85c \ud655\uc7a5\ub418\uba70 \ub2e8\uae30\uc801\uc778(\u22642\ub144) \uc131\uc7a5\uc5d0 \uac00\uc7a5 \ud070 \uc601\ud5a5\uc744 \ubbf8\uce69\ub2c8\ub2e4.<br \/>\n*   \ud658\uc790 \uc911\uc2ec \uc2e0\uc57d \uac1c\ubc1c\uc744 \uc704\ud55c \uaddc\uc81c \uac15\ud654 (+2.5% CAGR \uc601\ud5a5): FDA\uc758 \ud658\uc790 \uc911\uc2ec \uc2e0\uc57d \uac1c\ubc1c \ud504\ub85c\uadf8\ub7a8\uc740 \uc8fc\uc694 \uc5f0\uad6c\uc5d0\uc11c \ud658\uc790 \uacbd\ud5d8 \uce21\uc815\uc758 \uccb4\uacc4\uc801\uc778 \uc218\uc9d1\uc744 \uc758\ubb34\ud654\ud558\uc5ec, \ubaa9\uc801\uc5d0 \ub9de\ub294 eCOA \ud50c\ub7ab\ud3fc\uc758 \uc911\uc694\uc131\uc744 \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2024\ub144 10\uc6d4\uc5d0 \ubc1c\ud45c\ub41c \uc885\uc591\ud559 \ubd84\uc57c\uc758 \ud575\uc2ec \ud658\uc790 \ubcf4\uace0 \uacb0\uacfc\uc5d0 \ub300\ud55c \uc9c0\uce68\uc740 \ud45c\uc900\ud654\ub41c \ub3c4\uad6c \ud15c\ud50c\ub9bf\uc744 \uc81c\uacf5\ud558\uc5ec \ubc29\ubc95\ub860 \uac80\uc99d\uc758 \ubd88\ud655\uc2e4\uc131\uc744 \uc904\uc785\ub2c8\ub2e4. EMA\uc758 \ucef4\ud4e8\ud130 \uc2dc\uc2a4\ud15c\uc5d0 \ub300\ud55c \uad8c\uace0 \uc0ac\ud56d\uc740 \ub300\uc11c\uc591 \ud6a1\ub2e8 \uc815\ub82c\uc744 \ud1b5\ud574 \uae00\ub85c\ubc8c \uc784\uc0c1 \uc2dc\ud5d8\uc758 \uad6c\ud604 \ubcf5\uc7a1\uc131\uc744 \ub0ae\ucda5\ub2c8\ub2e4. \uc774\ub294 FDA\uc640 EMA\uc758 \uc8fc\ub3c4\ub85c \uc804 \uc138\uacc4\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\uce58\uba70 \uc7a5\uae30\uc801\uc778(\u22654\ub144) \uc131\uc7a5\uc744 \uc774\ub04c \uac83\uc785\ub2c8\ub2e4.<br \/>\n*   \ubd84\uc0b0\ud615 \ubc0f BYOD(Bring-Your-Own-Device) \uc784\uc0c1 \uc2dc\ud5d8 \ubaa8\ub378\ub85c\uc758 \uc804\ud658 \uac00\uc18d\ud654 (+3.4% CAGR \uc601\ud5a5): \ubd84\uc0b0\ud615 \uc124\uacc4\ub294 \ud604\uc7a5 \uc911\uc2ec \ubaa8\ub378\uc5d0 \ube44\ud574 10% \ub354 \ube60\ub978 \ud658\uc790 \ubaa8\uc9d1\uacfc \ud5a5\uc0c1\ub41c \uc778\uad6c \ud1b5\uacc4\ud559\uc801 \ub2e4\uc591\uc131\uc744 \ub2ec\uc131\ud569\ub2c8\ub2e4. 2024\ub144 9\uc6d4 FDA \uc9c0\uce68\uc740 \uc7ac\ud0dd \ubc29\ubb38, \uc6d0\uaca9 \uc758\ub8cc, \ud658\uc790 \uc9c1\uc811 IMP(Investigational Medicinal Product) \ubc30\uc1a1\uc744 \ud3ec\ud568\ud558\ub294 \uc784\uc0c1 \uc2dc\ud5d8\uc5d0 \ub300\ud55c \uc6b4\uc601 \uae30\ub300\uce58\ub97c \uba85\ud655\ud788 \ud558\uc5ec \ubd84\uc0b0\ud615 \uc784\uc0c1 \uc2dc\ud5d8\uc758 \uc815\ub2f9\uc131\uc744 \ud655\uace0\ud788 \ud569\ub2c8\ub2e4. BYOD \uc804\ub7b5\uc740 \ucc38\uac00\uc790\ub4e4\uc774 \uc775\uc219\ud55c \uc2a4\ub9c8\ud2b8\ud3f0\uc744 \uc0ac\uc6a9\ud558\ubbc0\ub85c \uc7a5\uce58 \uc870\ub2ec \ube44\uc6a9\uc744 \uc808\uac10\ud558\uace0 \uc21c\uc751\ub3c4\ub97c \ub192\uc774\uc9c0\ub9cc, \uc6b4\uc601 \uccb4\uc81c \uc804\ubc18\uc5d0 \uac78\uccd0 \uc5c4\uaca9\ud55c \ub3d9\ub4f1\uc131 \ud14c\uc2a4\ud2b8\uac00 \ud544\uc694\ud569\ub2c8\ub2e4. \uc774\ub294 \ubd81\ubbf8\uc640 \uc720\ub7fd\uc744 \uc911\uc2ec\uc73c\ub85c \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\uc73c\ub85c \ud655\uc0b0\ub418\uba70 \uc911\uae30\uc801\uc778(2-4\ub144) \uc131\uc7a5\uc5d0 \uac00\uc7a5 \ud070 \uc601\ud5a5\uc744 \ubbf8\uce69\ub2c8\ub2e4.<br \/>\n*   BYOD \uc9c0\uc6d0 \uc6e8\uc5b4\ub7ec\ube14\uc744 \ud1b5\ud55c \uc7a5\uce58 \ube44\uc6a9 \uc808\uac10 \ubc0f \uc21c\uc751\ub3c4 \ud5a5\uc0c1 (+1.9% CAGR \uc601\ud5a5):<br \/>\n*   AI \uae30\ubc18 \uc21c\uc751\ub3c4 \ucf54\uce6d\uc744 \ud1b5\ud55c PRO \ub370\uc774\ud130 \ud488\uc9c8 \ud5a5\uc0c1 (+1.8% CAGR \uc601\ud5a5):<\/p>\n<p># 3. \uc8fc\uc694 \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778 (Restraints)<\/p>\n<p>eCOA \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc8fc\uc694 \uc81c\uc57d \uc694\uc778\ub4e4\uc740 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \ub370\uc774\ud130 \ubcf4\uc548 \ubc0f \uac1c\uc778 \uc815\ubcf4 \uce68\ud574 \uc6b0\ub824 (-1.7% CAGR \uc601\ud5a5): FDA\ub294 \uc5f0\uacb0\ub41c \uc758\ub8cc \uae30\uc220\uc5d0 \ub300\ud55c \uc18c\ud504\ud2b8\uc6e8\uc5b4 \uc790\uc7ac \uba85\uc138\uc11c(SBOM)\ub97c \uc694\uad6c\ud558\uba70, eCOA \uacf5\uae09\uc5c5\uccb4\ub294 \uac15\ub825\ud55c \ucde8\uc57d\uc810 \ubaa8\ub2c8\ud130\ub9c1 \ud504\ub85c\uadf8\ub7a8\uc744 \uc720\uc9c0\ud574\uc57c \ud569\ub2c8\ub2e4. \uc720\ub7fd\uc758 GDPR\uc740 \uc5c4\uaca9\ud55c \ub370\uc774\ud130 \uc804\uc1a1 \uc81c\uc57d\uc744 \ucd94\uac00\ud558\uc5ec \uc2a4\ud3f0\uc11c\uac00 \uc9c0\uc5ed \ub370\uc774\ud130 \uc0c1\uc8fc \uc81c\uc5b4 \ubc0f \ub2e4\uce35 \uc554\ud638\ud654\ub97c \ubc30\ud3ec\ud558\ub3c4\ub85d \uac15\uc81c\ud569\ub2c8\ub2e4. 2024\ub144 FDA\uc758 Exer Labs\uc5d0 \ub300\ud55c \uacbd\uace0 \uc11c\ud55c\uacfc \uac19\uc740 \uc9d1\ud589 \uc870\uce58\ub294 \ubd80\uc801\uc808\ud55c \uc0ac\uc774\ubc84 \ubcf4\uc548\uc758 \uc7ac\uc815\uc801 \ubc0f \ud3c9\ud310\uc801 \uc704\ud5d8\uc744 \uac15\uc870\ud569\ub2c8\ub2e4. \uc774\ub294 GDPR\uc5d0 \ub530\ub77c EU\uc5d0 \ub300\ud55c \uc9d1\uc911\ub3c4\uac00 \ub192\uc544\uc9c0\uba70 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \ub2e8\uae30\uc801\uc778(\u22642\ub144) \uc601\ud5a5\uc744 \ubbf8\uce69\ub2c8\ub2e4.<br \/>\n*   \ub192\uc740 \ucd08\uae30 \uad6c\ud604 \ubc0f \uac80\uc99d \ube44\uc6a9 (-2.1% CAGR \uc601\ud5a5): 3\uc0c1 \uc784\uc0c1 \uc2dc\ud5d8\uc740 \uc774\ubbf8 \uac1c\ubc1c \uc608\uc0b0\uc758 \ub300\ubd80\ubd84\uc744 \ucc28\uc9c0\ud558\uba70, \uc7a5\uce58, \uc5b8\uc5b4 \ubc0f \uc778\uad6c \ud1b5\uacc4\ud559\uc801 \ud558\uc704 \uadf8\ub8f9 \uc804\ubc18\uc5d0 \uac78\uccd0 eCOA \uc18c\ud504\ud2b8\uc6e8\uc5b4\ub97c \uac80\uc99d\ud558\ub294 \ub370 \ucd94\uac00 \ube44\uc6a9\uc774 \ubc1c\uc0dd\ud569\ub2c8\ub2e4. eCOA \ucee8\uc18c\uc2dc\uc5c4\uc740 \uc13c\uc11c \uae30\ubc18 \ub370\uc774\ud130 \uc2a4\ud2b8\ub9bc\uc774 \ubaa9\uc801 \uc801\ud569\uc131 \ud3c9\uac00\ub97c \uac70\uccd0\uc57c \ud55c\ub2e4\uace0 \uac15\uc870\ud558\uba70 \ud504\ub85c\uc81d\ud2b8 \uc77c\uc815\uc744 \uc5f0\uc7a5\uc2dc\ud0b5\ub2c8\ub2e4. \uc6e8\uc5b4\ub7ec\ube14 \uac80\uc99d \uc5f0\uad6c\ub294 \ud604\uc7a5 \uac04 \uac00\ubcc0\uc131\uc744 \ubcf4\uc5ec\uc8fc\uc5b4 \uc2a4\ud3f0\uc11c\uac00 \uad11\ubc94\uc704\ud55c \ud45c\uc900\ud654 \ubc0f \ubaa8\ub2c8\ud130\ub9c1 \uc778\ud504\ub77c\uc5d0 \uc790\uae08\uc744 \uc9c0\uc6d0\ud558\ub3c4\ub85d \uc758\ubb34\ud654\ud569\ub2c8\ub2e4. \uc774\ub294 \uc18c\uaddc\ubaa8 \ubc14\uc774\uc624\ud14d \uae30\uc5c5\uc5d0 \ub354 \ud070 \uc601\ud5a5\uc744 \ubbf8 \ubbf8\uce58\uba70 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc911\uae30\uc801\uc778(2-4\ub144) \uc601\ud5a5\uc744 \ubbf8\uce69\ub2c8\ub2e4.<br \/>\n*   eCOA \uc219\ub828 \uc784\uc0c1 \uc6b4\uc601 \uc778\ub825 \ubd80\uc871 (-1.4% CAGR \uc601\ud5a5):<br \/>\n*   \uae30\uae30 \uc774\uc9c8\uc131\uc73c\ub85c \uc778\ud55c \uce21\uc815 \ub3d9\ub4f1\uc131 \uc704\ud5d8 (-1.2% CAGR \uc601\ud5a5):<\/p>\n<p># 4. \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p> 4.1. \uc81c\uacf5 \ubc29\uc2dd\ubcc4 (By Delivery Mode)<\/p>\n<p>*   \uc6f9 \ud638\uc2a4\ud305 \uc194\ub8e8\uc158: 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 73.61%\ub97c \ucc28\uc9c0\ud558\uba70 \uc5ec\uc804\ud788 \uc9c0\ubc30\uc801\uc785\ub2c8\ub2e4. \uc774\ub294 \ub9ce\uc740 \uc2a4\ud3f0\uc11c\uac00 \uae30\uc874 \ub370\uc774\ud130 \uc13c\ud130 \uacc4\uc57d\uc5d0 \uc758\uc874\ud558\uace0 \uc788\uc73c\uba70, \uc6f9 \ud638\uc2a4\ud305 \ubaa8\ub378\uc758 \uc775\uc219\ud568\uacfc \uac80\uc99d\ub41c \uac10\uc0ac \uc900\ube44 \uc0c1\ud0dc\uac00 \ub2e8\uae30\uc801\uc778 \uc120\ud638\ub97c \uc720\uc9c0\ud558\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \ud2b9\ud788 \uc5f0\uc18d\uc131\uc774 \ud601\uc2e0\ubcf4\ub2e4 \uc911\uc694\ud55c \ud6c4\uae30 \ub2e8\uacc4 \ud3ec\ud2b8\ud3f4\ub9ac\uc624\uc5d0\uc11c \uc120\ud638\ub429\ub2c8\ub2e4.<br \/>\n*   \ud074\ub77c\uc6b0\ub4dc \uae30\ubc18 \ud50c\ub7ab\ud3fc: 2031\ub144\uae4c\uc9c0 15.98%\uc758 CAGR\ub85c \ube60\ub974\uac8c \ud655\uc7a5\ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \uc2a4\ud3f0\uc11c\ub4e4\uc774 \ud0c4\ub825\uc801\uc778 \uc6a9\ub7c9, \uc2e4\uc2dc\uac04 \ubd84\uc11d, \uc790\ub3d9\ud654\ub41c \uaddc\uc81c \uc5c5\ub370\uc774\ud2b8\ub97c \ucd94\uad6c\ud558\ub294 \uacbd\ud5a5\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. Microsoft Azure\uc758 \ubcf4\uc548 \uc778\uc99d \ubc0f FDA\uac00 \uc2b9\uc778\ud55c \uc704\ud5d8 \uae30\ubc18 \uac80\uc99d\uc740 \ud074\ub77c\uc6b0\ub4dc \uc778\ud504\ub77c\uac00 \ub370\uc774\ud130 \ubb34\uacb0\uc131 \uc694\uad6c \uc0ac\ud56d\uc744 \ucda9\uc871\ud560 \uc218 \uc788\ub2e4\ub294 \uc2e0\ub8b0\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc2a4\ud3f0\uc11c\ub4e4\uc740 \ucd08\uae30 \ub2e8\uacc4 \ub610\ub294 \uad00\ucc30 \uc5f0\uad6c\ubd80\ud130 \uc2dc\uc791\ud558\uc5ec \ub0b4\ubd80 \uc815\ucc45\uc774 \uc131\uc219\ub418\uba74 \ud575\uc2ec \uc2dc\ud5d8\uc73c\ub85c \ub9c8\uc774\uadf8\ub808\uc774\uc158\ud558\ub294 \ubc29\uc2dd\uc73c\ub85c \uc810\uc9c4\uc801\uc73c\ub85c \uc6cc\ud06c\ub85c\ub4dc\ub97c \uc804\ud658\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 4.2. \uc811\uadfc \ubc29\uc2dd\ubcc4 (By Approach)<\/p>\n<p>*   \ud658\uc790 \ubcf4\uace0 \uacb0\uacfc(PRO): 2025\ub144 eCOA \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 48.45%\ub97c \ucc28\uc9c0\ud558\uba70, \uc624\ub79c FDA \ub77c\ubca8\ub9c1 \uc120\ub840\uc640 \ud658\uc790 \uc911\uc2ec \uc2e0\uc57d \uac1c\ubc1c \uc815\ucc45\uc5d0 \uc758\ud574 \ud655\uace0\ud788 \uc790\ub9ac \uc7a1\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc784\uc0c1\uc758 \ubcf4\uace0 \uacb0\uacfc(ClinRO): 2031\ub144\uae4c\uc9c0 16.05%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \uc784\uc0c1 \uc5f0\uad6c\uc790\ub4e4\uc774 \uc804\uc790 \uac74\uac15 \uae30\ub85d(EHR) \ud658\uacbd \ub0b4\uc5d0\uc11c \uc9c1\uc811 \uc810\uc218\ub97c \uc785\ub825\ud560 \uc218 \uc788\ub294 \ub0b4\uc7a5\ud615 eSource \ubaa8\ub4c8\uc5d0 \uc758\ud574 \ucd94\uc9c4\ub429\ub2c8\ub2e4. \uc790\uc5f0\uc5b4 \ucc98\ub9ac(NLP)\ub294 \ube44\uc815\ud615 \uc11c\uc220 \ud544\ub4dc\ub97c \uad6c\uc870\ud654\ub41c ClinRO \ubcc0\uc218\ub85c \ubcc0\ud658\ud558\uc5ec \ubc14\uc05c \uc758\uc0ac\ub4e4\uc758 \uc2dc\uac04 \ubd80\ub2f4\uacfc \uc624\ub958\uc728\uc744 \uc904\uc785\ub2c8\ub2e4.<br \/>\n*   \uad00\ucc30\uc790 \ubcf4\uace0 \uce21\uc815(ObsRO): \uc18c\uc544\uacfc \ubc0f \uce58\ub9e4 \ubd84\uc57c\uc5d0\uc11c \ud2b9\uc218 \uc6a9\ub3c4\ub85c \uc0ac\uc6a9\ub429\ub2c8\ub2e4.<br \/>\n*   \uc218\ud589 \uacb0\uacfc(PerfO): \ubcf4\ud589 \uc18d\ub3c4, \uc2ec\ubc15\uc218 \ubcc0\ub3d9\uc131 \ub4f1 \uac80\uc99d\ub41c \ub514\uc9c0\ud138 \ubc14\uc774\uc624\ub9c8\ucee4\uc640 \ud568\uaed8 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 4.3. \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4 (By End User)<\/p>\n<p>*   \uc81c\uc57d \ubc0f \ubc14\uc774\uc624 \uc81c\uc57d \ud68c\uc0ac: 2025\ub144 eCOA \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 56.72%\ub97c \ucc28\uc9c0\ud558\uba70, \ub4f1\ub85d \ub370\uc774\ud130 \ubb34\uacb0\uc131\uc5d0 \ub300\ud55c \uc9c1\uc811\uc801\uc778 \ucc45\uc784\uac10\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4.<br \/>\n*   \uacc4\uc57d \uc5f0\uad6c \uae30\uad00(CRO): 2031\ub144\uae4c\uc9c0 16.02%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \uc2a4\ud3f0\uc11c\uac00 \uc6b4\uc601 \ubcf5\uc7a1\uc131\uc744 \uc678\ubd80\ud654\ud558\ub294 \uad11\ubc94\uc704\ud55c \uc544\uc6c3\uc18c\uc2f1 \ucd94\uc138\ub97c \ubc18\uc601\ud569\ub2c8\ub2e4. \uc120\ub3c4\uc801\uc778 CRO\ub4e4\uc740 eCOA \uae30\ub2a5\uc744 \ud604\uc7a5 \uacb0\uc81c, eConsent, \ubb34\uc791\uc704 \ubc30\uc815\uacfc \ud1b5\ud569\ud558\uc5ec \ud1b5\ud569 \ub514\uc9c0\ud138 \uc2dc\ud5d8 \uccad\uc0ac\uc9c4\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   \uae30\ud0c0 (\ud559\uc220 \uc758\ub8cc \uc13c\ud130 \ubc0f \uc815\ubd80 \uae30\uad00): \uc0c1\uc5c5\uc801 \uc778\uc13c\ud2f0\ube0c\uac00 \uc81c\ud55c\uc801\uc778 \ud76c\uadc0 \uc9c8\ud658 \ucf54\ud638\ud2b8\uc5d0\uc11c \uc0c8\ub85c\uc6b4 \ub514\uc9c0\ud138 \uc5d4\ub4dc\ud3ec\uc778\ud2b8\ub97c \uc2dc\ubc94 \uc6b4\uc601\ud558\uc5ec \ud601\uc2e0\uc744 \uc8fc\ub3c4\ud569\ub2c8\ub2e4.<\/p>\n<p># 5. \uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 41.76%\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728\ub85c eCOA \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc5c4\uaca9\ud558\uc9c0\ub9cc \uba85\ud655\ud558\uac8c \uc815\uc758\ub41c FDA \uaddc\uc81c, \uc815\uad50\ud55c \uc784\uc0c1 \uc5f0\uad6c \uc778\ud504\ub77c, \ud658\uc790 \uc911\uc2ec \uc9c0\ud45c\uc758 \uc870\uae30 \ubc30\ud3ec\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. \ubbf8\uad6d\uc774 \ub300\ubd80\ubd84\uc758 \uc9c0\uc5ed \uc218\uc775\uc744 \ucc28\uc9c0\ud558\uba70, \uce90\ub098\ub2e4\ub294 \ud76c\uadc0 \uc9c8\ud658\uc5d0 \ub300\ud55c \ud2b9\uc218 Day-1 \uc811\uadfc \ud504\ub85c\uadf8\ub7a8\uc744, \uba55\uc2dc\ucf54\ub294 \ube44\uc6a9 \ud6a8\uc728\uc801\uc778 1\uc0c1 \uc5f0\uad6c \ub2e8\uc704\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 16.29%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub978 \uc9c0\uc5ed \ud655\uc7a5\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \uc870\ud654\ub85c\uc6b4 \uc784\uc0c1 \uc2dc\ud5d8 \uc815\ucc45, \uad6d\ub0b4 R&#038;D \ud22c\uc790 \uc99d\uac00, \ud658\uc790\ub2f9 \ub0ae\uc740 \ube44\uc6a9\uc758 \uac00\ub2a5\uc131\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. \uc911\uad6d\uc758 \uc784\uc0c1 \uc2dc\ud5d8 \uc2b9\uc778 \uc808\ucc28 \uac04\uc18c\ud654, \uc778\ub3c4\uc758 \ub514\uc9c0\ud138 \uac74\uac15 \ubbf8\uc158, \ud55c\uad6d\uc758 \uc6d0\uaca9 \uc758\ub8cc \uc2dc\ubc94 \uc0ac\uc5c5\uc740 \uac15\ub825\ud55c eCOA \ubc31\ubcf8\uc744 \ud544\uc694\ub85c \ud558\ub294 \ubd84\uc0b0\ud615 \uc5f0\uad6c \uc124\uacc4\uc5d0 \uc6b0\ud638\uc801\uc778 \ud658\uacbd\uc744 \uc870\uc131\ud569\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: EMA\uc758 \uc870\ud654\uc640 \uad6d\uac00\ubcc4 eHealth \uc758\uc81c\uc5d0 \ud798\uc785\uc5b4 \uc548\uc815\uc801\uc778 \ucc44\ud0dd\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub3c5\uc77c\uc758 \ubcd1\uc6d0 \ub514\uc9c0\ud138\ud654 \uc608\uc0b0\uacfc \uc601\uad6d\uc758 \uc758\uc57d\ud488 \ubc0f \uc758\ub8cc \uc81c\ud488 \uaddc\uc81c \uae30\uad00(MHRA) \uc0cc\ub4dc\ubc15\uc2a4\ub294 \uc885\uc591\ud559 \ubc0f \uc2e0\uacbd\ud559 \ubd84\uc57c\uc5d0\uc11c \uc13c\uc11c \uae30\ubc18 \uacb0\uacfc\uc758 \ucc44\ud0dd\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4.<\/p>\n<p># 6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>eCOA \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc785\ub2c8\ub2e4. Medidata, Signant Health, Clario\uac00 \uc0c1\ub2f9\ud55c \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc9c0\ub9cc, \uc218\ub9ce\uc740 \uc911\uacac \ubc0f \uc2e0\ud765 \uacf5\uae09\uc5c5\uccb4\ub4e4\uc774 \uc804\ubb38 \ud2c8\uc0c8\uc2dc\uc7a5\uc744 \uacf5\ub7b5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. Medidata\ub294 eCOA\ub97c \ud1b5\ud569 \uc784\uc0c1 \ud50c\ub7ab\ud3fc\uc5d0 \ud1b5\ud569\ud558\uace0 Site Insights Program\uc744 \ucd9c\uc2dc\ud558\uc5ec \ub9ac\ub354\uc2ed\uc744 \ud655\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. Signant Health\ub294 IQVIA\uc640 \ud611\ub825\ud558\uc5ec One Home for Sites \ud504\ub808\uc784\uc6cc\ud06c\ub97c \ud1b5\ud574 \uc5f0\uad6c\uc790 \ud3ec\ud138\uacfc \uc804\uc790 \uc18c\uc2a4\ub97c \ud1b5\ud569\ud558\uc5ec \uc6cc\ud06c\ud50c\ub85c\uc6b0 \ud6a8\uc728\uc131\uc744 \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. Clario\ub294 WCG\uc758 eCOA \uc0ac\uc5c5\ubd80\ub97c \uc778\uc218\ud558\uc5ec \uc9c0\ub9ac\uc801 \ub3c4\ub2ec \ubc94\uc704\ub97c \ub113\ud788\uace0 \ubcf5\uc7a1\ud55c \uce58\ub8cc \uc601\uc5ed\uc5d0 \ub300\ud55c \uc804\ubb38\uc131\uc744 \uc2ec\ud654\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2e0\uaddc \uc9c4\uc785\uc790\ub4e4\uc740 \uc778\uacf5\uc9c0\ub2a5(AI) \ubaa8\ub4c8\uc744 \ud1b5\ud574 \ucc28\ubcc4\ud654\ub97c \uaf80\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. Kayentis\ub294 \uc21c\uc751\ub3c4 \ud328\ud134\uc744 \ubd84\uc11d\ud558\uc5ec \uac1c\uc778\ud654\ub41c \uc54c\ub9bc\uc744 \uc81c\uacf5\ud558\uba70, Medable Studio\ub294 \ub2e4\uad6d\uc5b4 \ub3c4\uad6c\uc758 \ub4dc\ub798\uadf8 \uc564 \ub4dc\ub86d \uad6c\uc131\uc744 \ud1b5\ud574 \uad6c\ucd95 \uc2dc\uac04\uc744 \ub2e8\ucd95\ud569\ub2c8\ub2e4. Oracle\uacfc Veeva Systems\ub294 \uc6b4\uc601 \ubc0f \uc784\uc0c1 \uc2e0\ud638\ub97c \ud1b5\ud569\ud558\ub294 \uc5d4\ud130\ud504\ub77c\uc774\uc988\uae09 \ub370\uc774\ud130 \ub808\uc774\ud06c\ub97c \uad6c\ucd95\ud558\uc5ec \uc2e4\uc2dc\uac04 \uc704\ud5d8 \uae30\ubc18 \ubaa8\ub2c8\ud130\ub9c1\uc744 \uc57d\uc18d\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ud1b5\ud569 \uc18d\uc5d0\uc11c\ub3c4 \ud604\uc9c0 \uc5b8\uc5b4 \uc9c0\uc6d0, \uc624\ud504\ub77c\uc778 \uae30\ub2a5, \uacac\uace0\ud55c \ud558\ub4dc\uc6e8\uc5b4\uac00 \ud544\uc218\uc801\uc778 \uc800\uc790\uc6d0 \ud658\uacbd\uc5d0\uc11c\ub294 \uc5ec\uc804\ud788 \uae30\ud68c\uac00 \ub0a8\uc544 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc694\uad6c \uc0ac\ud56d\uc744 \ucda9\uc871\ud560 \uc218 \uc788\ub294 \uacf5\uae09\uc5c5\uccb4\ub294 \uc2a4\ud3f0\uc11c\uac00 \uc544\ud504\ub9ac\uce74 \ubc0f \ub77c\ud2f4 \uc544\uba54\ub9ac\uce74\ub85c \uc784\uc0c1 \uc2dc\ud5d8\uc744 \ud655\uc7a5\ud568\uc5d0 \ub530\ub77c \ucd94\uac00\uc801\uc778 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ud655\ubcf4\ud560 \uc218 \uc788\uc744 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec \uae30\uc5c5: Kayentis, IQVIA Inc., Parexel International Corporation, Signant Health, WIRB-Copernicus Group \ub4f1.<\/p>\n<p># 7. \ucd5c\uadfc \uc0b0\uc5c5 \ubc1c\uc804<\/p>\n<p>*   2025\ub144 5\uc6d4: Clario\ub294 WCG\ub85c\ubd80\ud130 \uc804\uc790 \uc784\uc0c1 \uacb0\uacfc \ud3c9\uac00 \uc0ac\uc5c5\uc744 \uc778\uc218\ud558\uc5ec \uae00\ub85c\ubc8c \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uc704\ud55c \ud3ec\uad04\uc801\uc778 \uc194\ub8e8\uc158 \uc81c\uacf5 \uc5ed\ub7c9\uc744 \uac15\ud654\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 3\uc6d4: Medidata Solutions\ub294 Site Insights Program\uc744 \ucd9c\uc2dc\ud558\uc5ec \ud604\uc7a5 \ucc38\uc5ec\ub97c \ub192\uc774\uace0 \uc5f0\uad6c \uc124\uacc4 \ud53c\ub4dc\ubc31\uc744 \ud1b5\ud569 \ud50c\ub7ab\ud3fc\uc5d0 \uc9c1\uc811 \ubc18\uc601\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 1\uc6d4: Suvoda\uc640 Greenphire\ub294 \ud569\ubcd1\uc744 \ubc1c\ud45c\ud558\uc5ec \ubb34\uc791\uc704 \ubc30\uc815, \uacf5\uae09 \uad00\ub9ac, eConsent, eCOA \ubc0f \ud658\uc790 \uacb0\uc81c\ub97c \ud3ec\uad04\ud558\ub294 \ud1b5\ud569 \uc784\uc0c1 \uc2dc\ud5d8 \uae30\uc220 \uc2a4\uc704\ud2b8\ub97c \ud615\uc131\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 8\uc6d4: Medable\uc740 \ub2e4\uc911 \uad6c\uc131 \uc694\uc18c eCOA \ubc30\ud3ec\ub97c \uad6c\uc131\ud558\uace0 \uac80\uc99d\ud558\uae30 \uc704\ud55c \uc62c\uc778\uc6d0 \ud658\uacbd\uc778 Medable Studio\ub97c \ucd9c\uc2dc\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p># \uacb0\ub860<\/p>\n<p>\uc804\uc790 \uc784\uc0c1 \uacb0\uacfc \ud3c9\uac00 \uc194\ub8e8\uc158(eCOA) \uc2dc\uc7a5\uc740 \uaddc\uc81c \ud658\uacbd\uc758 \ubcc0\ud654, \ud074\ub77c\uc6b0\ub4dc \uae30\uc220\uc758 \ubc1c\uc804, \ubd84\uc0b0\ud615 \uc784\uc0c1 \uc2dc\ud5d8 \ubaa8\ub378\uc758 \ud655\uc0b0\uc5d0 \ud798\uc785\uc5b4 \ud5a5\ud6c4 \uba87 \ub144\uac04 \uc0c1\ub2f9\ud55c \uc131\uc7a5\uc744 \uc9c0\uc18d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ub370\uc774\ud130 \ubcf4\uc548 \ubc0f \ub192\uc740 \ucd08\uae30 \ube44\uc6a9\uacfc \uac19\uc740 \ub3c4\uc804 \uacfc\uc81c\uac00 \uc874\uc7ac\ud558\uc9c0\ub9cc, \ud601\uc2e0\uc801\uc778 \uae30\uc220\uacfc \uc804\ub7b5\uc801 \ud30c\ud2b8\ub108\uc2ed\uc744 \ud1b5\ud574 \uc2dc\uc7a5\uc740 \ub354\uc6b1 \uc131\uc219\ud558\uace0 \ud655\uc7a5\ub420 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc804\uc790 \uc784\uc0c1 \uacb0\uacfc \ud3c9\uac00 \uc194\ub8e8\uc158(eCOA) \uc2dc\uc7a5 \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc804\uc790 \uc784\uc0c1 \uacb0\uacfc \ud3c9\uac00(eCOA) \uc194\ub8e8\uc158 \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. eCOA\ub294 \uc2a4\ub9c8\ud2b8\ud3f0, \ud0dc\ube14\ub9bf, \ucef4\ud4e8\ud130 \ub4f1 \uae30\uc220\uc744 \ud65c\uc6a9\ud558\uc5ec \ud658\uc790, \uac04\ubcd1\uc778, \uc758\uc0ac\uac00 \uc784\uc0c1 \uc2dc\ud5d8 \uacb0\uacfc\ub97c \uc9c1\uc811 \ubcf4\uace0\ud560 \uc218 \uc788\ub3c4\ub85d \ud558\ub294 \uc2dc\uc2a4\ud15c\uc785\ub2c8\ub2e4. \uc774\ub294 \ub9e4\uc6b0 \uc815\ud655\ud55c \ub370\uc774\ud130\ub97c \uc0dd\uc131\ud558\uc5ec \uc784\uc0c1 \uc2dc\ud5d8\uc5d0\uc11c \ud658\uc790 \uacbd\ud5d8\uc5d0 \ub300\ud55c \uc774\ud574\ub97c \ub192\uc774\uace0 \uad81\uadf9\uc801\uc73c\ub85c \uc2e0\uc57d \uc2b9\uc778 \uacfc\uc815\uc744 \uac04\uc18c\ud654\ud558\ub294 \ub370 \uae30\uc5ec\ud569\ub2c8\ub2e4.<\/p>\n<p>eCOA \uc2dc\uc7a5\uc740 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 15.42%\uc758 \uacac\uace0\ud55c \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \uc81c\uc57d \ubc0f \ubc14\uc774\uc624 \uae30\uc5c5\uc758 \uc784\uc0c1 \uc2dc\ud5d8 \uc544\uc6c3\uc18c\uc2f1 \uc99d\uac00, \ud074\ub77c\uc6b0\ub4dc\/SaaS \uae30\ubc18 eClinical \uc2a4\ud0dd\uc758 \ud655\uc7a5, \ud658\uc790 \uc911\uc2ec \uc2e0\uc57d \uac1c\ubc1c\uc5d0 \ub300\ud55c \uaddc\uc81c \uac15\ud654, \ubd84\uc0b0\ud615 \ubc0f BYOD(Bring Your Own Device) \uc784\uc0c1 \uc2dc\ud5d8 \ubaa8\ub378\ub85c\uc758 \uc804\ud658 \uac00\uc18d\ud654\uc5d0 \uc758\ud574 \uc8fc\ub3c4\ub429\ub2c8\ub2e4. \ud2b9\ud788, BYOD \uc9c0\uc6d0 \uc6e8\uc5b4\ub7ec\ube14 \uae30\uae30\ub294 \uae30\uae30 \ube44\uc6a9\uc744 \uc808\uac10\ud558\uace0 \uaddc\uc815 \uc900\uc218\ub97c \ud5a5\uc0c1\uc2dc\ud0a4\uba70, AI \uae30\ubc18 \uc21c\uc751\ub3c4 \ucf54\uce6d\uc740 \ud658\uc790 \ubcf4\uace0 \uacb0\uacfc(PRO) \ub370\uc774\ud130 \ud488\uc9c8\uc744 \ub192\uc774\ub294 \ub370 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uadf8\ub7ec\ub098 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0\ub294 \uba87 \uac00\uc9c0 \uc81c\uc57d \uc694\uc778\ub3c4 \uc874\uc7ac\ud569\ub2c8\ub2e4. \uc5c4\uaca9\ud55c \uac1c\uc778\uc815\ubcf4 \ubcf4\ud638 \uaddc\uc81c \ud558\uc758 \ub370\uc774\ud130 \ubcf4\uc548 \ubc0f \uac1c\uc778\uc815\ubcf4 \uce68\ud574 \uc6b0\ub824, \ub192\uc740 \ucd08\uae30 \uad6c\ud604 \ubc0f \uac80\uc99d \ube44\uc6a9, eCOA \uc219\ub828 \uc784\uc0c1 \uc6b4\uc601 \uc778\ub825 \ubd80\uc871, \uadf8\ub9ac\uace0 \uae30\uae30 \uc774\uc9c8\uc131\uc73c\ub85c \uc778\ud55c \uce21\uc815 \ub3d9\ub4f1\uc131 \uc704\ud5d8 \ub4f1\uc774 \uc8fc\uc694 \uc7a5\uc560\ubb3c\ub85c \uaf3d\ud799\ub2c8\ub2e4. \ud2b9\ud788 \uc18c\uaddc\ubaa8 \ubc14\uc774\uc624\uae30\uc220 \uae30\uc5c5\uc5d0\uac8c\ub294 \ub192\uc740 \uac80\uc99d \ube44\uc6a9\uc774 \ud070 \ubd80\ub2f4\uc774 \ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc138\ubd84\ud654 \ubc0f \uc8fc\uc694 \ub3d9\ud5a5\uc744 \uc0b4\ud3b4\ubcf4\uba74 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc81c\uacf5 \ubc29\uc2dd\ubcc4: \ud074\ub77c\uc6b0\ub4dc \uae30\ubc18 \ud50c\ub7ab\ud3fc\uc774 \uc5f0\ud3c9\uade0 15.98%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uba70, \ud655\uc7a5\uc131\uacfc \uaddc\uc815 \uc900\uc218 \uce21\uba74\uc5d0\uc11c \uc6f9 \ud638\uc2a4\ud305 \ubc0f \uc628\ud504\ub808\ubbf8\uc2a4 \ubaa8\ub378\uc744 \ub2a5\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc811\uadfc \ubc29\uc2dd\ubcc4: \ud658\uc790 \ubcf4\uace0 \uacb0\uacfc(PRO), \uc784\uc0c1\uc758 \ubcf4\uace0 \uacb0\uacfc(ClinRO), \uad00\ucc30\uc790 \ubcf4\uace0 \uacb0\uacfc(ObsRO), \uc131\uacfc \uacb0\uacfc(PerfO)\ub85c \uad6c\ubd84\ub429\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \uc81c\uc57d \ubc0f \ubc14\uc774\uc624 \uc81c\uc57d \ud68c\uc0ac, \uc784\uc0c1 \uc2dc\ud5d8 \uc218\ud0c1 \uae30\uad00(CRO), \uae30\ud0c0\ub85c \ub098\ub269\ub2c8\ub2e4. CRO\ub294 \uc778\ub825 \ubd80\uc871 \ud574\uc18c \ubc0f \uc804\ubb38 \ub514\uc9c0\ud138 \uc804\ubb38\uc131 \ud65c\uc6a9\uc744 \uc704\ud574 \uc2a4\ud3f0\uc11c\ub4e4\uc774 \uc784\uc0c1 \uc2dc\ud5d8 \uc2e4\ud589\uc744 \uc544\uc6c3\uc18c\uc2f1\ud568\uc5d0 \ub530\ub77c \uc5f0\ud3c9\uade0 16.02%\uc758 \uc131\uc7a5\ub960\ub85c \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uaddc\uc81c \uc870\ud654 \ubc0f \ube44\uc6a9 \ud6a8\uc728\uc801\uc778 \ud658\uc790 \ubaa8\uc9d1\uc5d0 \ud798\uc785\uc5b4 \uc5f0\ud3c9\uade0 16.29%\ub85c \uac00\uc7a5 \ud070 \uc131\uc7a5 \uae30\ud68c\ub97c \uc81c\uacf5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ubd81\ubbf8(\ubbf8\uad6d, \uce90\ub098\ub2e4, \uba55\uc2dc\ucf54), \uc720\ub7fd(\ub3c5\uc77c, \uc601\uad6d, \ud504\ub791\uc2a4, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778 \ub4f1), \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8 \uc9c0\uc5ed\ub3c4 \ubd84\uc11d\uc5d0 \ud3ec\ud568\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \uce21\uba74\uc5d0\uc11c, \ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, \uadf8\ub9ac\uace0 Dassault Systemes (Medidata), Signant Health, Clario (ERT Clinical), Oracle Corporation, IQVIA Inc., Veeva Systems \ub4f1 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc758 \ud504\ub85c\ud544\uc744 \uc0c1\uc138\ud788 \ub2e4\ub8f9\ub2c8\ub2e4. \uc778\uacf5\uc9c0\ub2a5(AI)\uc740 \uc21c\uc751\ub3c4 \ucf54\uce6d, \uacb0\uacfc \uc608\uce21, \uc790\ub3d9\ud654\ub41c \ub370\uc774\ud130 \ud488\uc9c8 \uac80\uc0ac \ub4f1\uc5d0\uc11c \uba38\uc2e0\ub7ec\ub2dd \ubaa8\ub4c8\uc744 \ud1b5\ud569\ud558\uc5ec \ud50c\ub7ab\ud3fc \ucc28\ubcc4\ud654\ub97c \uac15\ud654\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 \uc2a4\ud3f0\uc11c\uc640 \uc784\uc0c1 \ud604\uc7a5\uc5d0 \ub300\ud55c \uac00\uce58\ub97c \ub192\uc774\ub294 \uc911\uc694\ud55c \uc694\uc18c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-31295","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/31295"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=31295"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/31295\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=31295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=31295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=31295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}